Measuring and Valuing Outcomes - OHE

We found for

Past Event
Seminar
April 2023

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

G7Antibiotics_blog_featuredimage

Insight
December 2022

G7 Investments in New Antibiotics Would Pay Off – For Everyone

jacek-dylag-IiQXLbTTQCw-unsplash-scaled-1

Insight
December 2022

ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”

News
July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Choices_Brian-Jackson_AdobeStock_137193688-e1673972063160

Insight
May 2022

Accounting for Preference Heterogeneity in Discrete Choice Experiments

Past Event
Masterclass
March 2022

Severity in Value Assessment: From Principle to Practice

Insight
March 2022

Including Carer Quality of Life in Health Technology Evaluation: Are We There Yet?

Insight
March 2022

To Hell with the 3L! NICE’s Missed Opportunity to Upgrade Health Outcome Measurement

Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

Read more

© NCI/Unsplash

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Read more

© WellcomeCollection

Insight
June 2021

Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

Read more

© Rawpixel.com

Insight
January 2021

OHE at HESG Winter 2021

How is Quality of Life Measured for Health Technology Assessments?

Read more

Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology

Read more

News
December 2020

Should We ‘Drop Dead’ from Health State Valuation?